Terazosin Hydrochloride is Used for treating hypertension and symptomatic benign prostatic hyperplasia. It was first introduced by Abbott Laboratories Pharmaceutical Products Div in its drug Hytrin on Aug 7, 1987. Another drug containing Terazosin Hydrochloride is Tezruly. 13 different companies have introduced drugs containing Terazosin Hydrochloride.
Terazosin Hydrochloride Patents
Given below is the list of patents protecting Terazosin Hydrochloride, along
with the drug name that holds that patent and the company name owning that
drug.
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Terazosin Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Terazosin Hydrochloride. The first generic version for Terazosin Hydrochloride was by Apnar Pharma Lp and was approved on Mar 30, 1998. And the latest generic version is by Jubilant Cadista Pharmaceuticals Inc and was approved on Dec 20, 2004.
Given below is the list of companies who have filed for
Terazosin Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. APNAR PHARMA LP
Apnar Pharma Lp has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the
details of the strengths of this generic introduced by
Apnar Pharma Lp.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 1MG BASE
capsule
Prescription
ORAL
AB
Mar 30, 1998
EQ 2MG BASE
capsule
Prescription
ORAL
AB
Mar 30, 1998
EQ 5MG BASE
capsule
Prescription
ORAL
AB
Mar 30, 1998
EQ 10MG BASE
capsule
Prescription
ORAL
AB
Mar 30, 1998
2. BIONPHARMA
Bionpharma Inc has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the
details of the strengths of this generic introduced by
Bionpharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE
capsule
Prescription
ORAL
AB
Jul 28, 2000
EQ 5MG BASE
capsule
Prescription
ORAL
AB
Jul 28, 2000
EQ 2MG BASE
capsule
Prescription
ORAL
AB
Jul 28, 2000
EQ 1MG BASE
capsule
Prescription
ORAL
AB
Jul 28, 2000
Manufacturing Plant Locations
New
Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.
Country
City
Firm Name
United States
Princeton
Bionpharma Inc.
3. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the
details of the strengths of this generic introduced by
Chartwell Rx.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 2MG BASE
tablet
Discontinued
ORAL
N/A
Apr 28, 2000
EQ 1MG BASE
tablet
Discontinued
ORAL
N/A
Apr 28, 2000
EQ 5MG BASE
tablet
Discontinued
ORAL
N/A
Apr 28, 2000
EQ 10MG BASE
tablet
Discontinued
ORAL
N/A
Apr 28, 2000
4. HERITAGE PHARMA AVET
Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the
details of the strengths of this generic introduced by
Heritage Pharma Avet.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 2MG BASE
capsule
Prescription
ORAL
AB
Jan 30, 2001
EQ 10MG BASE
capsule
Prescription
ORAL
AB
Jan 30, 2001
EQ 5MG BASE
capsule
Prescription
ORAL
AB
Jan 30, 2001
EQ 1MG BASE
capsule
Prescription
ORAL
AB
Jan 30, 2001
5. HIKMA
Hikma Pharmaceuticals International Ltd has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the
details of the strengths of this generic introduced by
Hikma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 5MG BASE
capsule
Discontinued
ORAL
N/A
Apr 12, 2001
EQ 1MG BASE
capsule
Discontinued
ORAL
N/A
Apr 12, 2001
EQ 2MG BASE
capsule
Discontinued
ORAL
N/A
Apr 12, 2001
EQ 10MG BASE
capsule
Discontinued
ORAL
N/A
Apr 12, 2001
Manufacturing Plant Locations
New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country
City
Firm Name
United States
Dayton
Hikma Injectables USA Inc
Carlsbad
Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Eatontown
Hikma Pharmaceuticals USA, Inc.
Cherry Hill
Hikma Pharmaceuticals USA Inc.
Portugal
Terrugem Snt
Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman
Hikma Pharmaceuticals LLC
6. IVAX SUB TEVA PHARMS
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the
details of the strengths of this generic introduced by
Ivax Sub Teva Pharms.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE
tablet
Discontinued
ORAL
N/A
Apr 21, 2000
EQ 5MG BASE
tablet
Discontinued
ORAL
N/A
Apr 21, 2000
EQ 2MG BASE
tablet
Discontinued
ORAL
N/A
Apr 21, 2000
EQ 1MG BASE
tablet
Discontinued
ORAL
N/A
Apr 21, 2000
7. JUBILANT CADISTA
Jubilant Cadista Pharmaceuticals Inc has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the
details of the strengths of this generic introduced by
Jubilant Cadista.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE
capsule
Prescription
ORAL
AB
Dec 20, 2004
EQ 5MG BASE
capsule
Prescription
ORAL
AB
Dec 20, 2004
EQ 2MG BASE
capsule
Prescription
ORAL
AB
Dec 20, 2004
EQ 1MG BASE
(reference standard)
capsule
Prescription
ORAL
AB
Dec 20, 2004
Manufacturing Plant Locations
New
Jubilant Cadista's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Jubilant Cadista as present at those locations.
Country
City
Firm Name
United States
Salisbury
Jubilant Cadista Pharmaceuticals, Inc.
8. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the
details of the strengths of this generic introduced by
Norvium Bioscience.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE
capsule
Discontinued
ORAL
N/A
Dec 1, 2000
EQ 2MG BASE
capsule
Discontinued
ORAL
N/A
Dec 1, 2000
EQ 1MG BASE
capsule
Discontinued
ORAL
N/A
Dec 1, 2000
EQ 5MG BASE
capsule
Discontinued
ORAL
N/A
Dec 1, 2000
9. RANBAXY LABS LTD
Ranbaxy Laboratories Ltd has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the
details of the strengths of this generic introduced by
Ranbaxy Labs Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 1MG BASE
capsule
Discontinued
ORAL
N/A
Aug 22, 2002
EQ 2MG BASE
capsule
Discontinued
ORAL
N/A
Aug 22, 2002
EQ 5MG BASE
capsule
Discontinued
ORAL
N/A
Aug 22, 2002
EQ 10MG BASE
capsule
Discontinued
ORAL
N/A
Aug 22, 2002
10. SANDOZ
Sandoz Inc has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the
details of the strengths of this generic introduced by
Sandoz.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 1MG BASE
tablet
Discontinued
ORAL
N/A
Dec 31, 1998
EQ 2MG BASE
tablet
Discontinued
ORAL
N/A
Dec 31, 1998
EQ 5MG BASE
tablet
Discontinued
ORAL
N/A
Dec 31, 1998
EQ 10MG BASE
tablet
Discontinued
ORAL
N/A
Dec 31, 1998
Manufacturing Plant Locations
New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
Country
City
Firm Name
Austria
Kundl
Sandoz GmbH
Langkampfen
Sandoz GmbH
United States
Princeton
Sandoz Inc
East Hanover
Sandoz Incorporated
Spain
Les Franqueses Del Valles
Sandoz Industrial Products S.A.
Palafolls
Sandoz Industrial Products, S.A.
India
Navi Mumbai
Sandoz Private Limited
11. TEVA
Teva Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the
details of the strengths of this generic introduced by
Teva.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 5MG BASE
tablet
Discontinued
ORAL
N/A
May 18, 2000
EQ 1MG BASE
tablet
Discontinued
ORAL
N/A
May 18, 2000
EQ 10MG BASE
tablet
Discontinued
ORAL
N/A
May 18, 2000
EQ 2MG BASE
tablet
Discontinued
ORAL
N/A
May 18, 2000
Manufacturing Plant Locations
New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
